This study evaluated the feasibility, safety, and findings from a protocol for exercise-bicycle ergometry in subacute-stroke survivors. Of 117 eligible candidates, 14 could not perform the test and 3 discontinued because of cardiac safety criteria. In the 100 completed tests, peak heart rate was 116 ± 19.1 beats/ min; peak VO 2 was 11.4 ± 3.7 ml · kg · min -1 , peak METs were 3.3 ± 0.91, exercise duration was 5.1 ± 2.84 min., and Borg score was 14 ± 2.6. Among 71 tests, anaerobic threshold was achieved in 3.0 ± 1.7 min with a VO 2 of 8.6 ± 1.7 ml · kg · min -1 . After screening, this protocol is feasible and safe in subacutestroke survivors with mild to moderate deficits. These stroke survivors have severely limited functional exercise capacity. Research and clinical practice in stroke rehabilitation should incorporate more comprehensive evaluation and treatment of endurance limitations.
by Duncan et al. (1998) , none of the 6 stroke survivors in the usual-care group who received rehabilitation services were given any form of endurance training .
There are serious barriers to the assessment and treatment of limited exercise capacity after stroke. Treadmill exercise testing can be used to diagnose exerciseinduced cardiac risk and to devise an exercise prescription. It can help detect serious ischemia or other exercise-induced cardiac abnormalities and can provide data about baseline exercise performance. Standard treadmill testing can be difficult for any older adult with conditions limiting walking and is especially difficult in stroke survivors who have impairments in lower extremity strength and coordination. Bicycle ergometry provides advantages over treadmill testing, especially for stroke survivors who have difficulty walking (Potempa et al., 1996) . For the many stroke survivors with impairments in gait, balance, and coordination, bicycle ergometry poses a lower risk of falling than does treadmill testing. Bicycle ergometry provides a clearer estimate of workload than treadmill testing does, because stride length, arm swing, and use of railings vary in treadmill testing whereas cycle rate and arm use are standardized in bicycle ergometry. The reduced arm motion in bicycle ergometry makes blood-pressure monitoring more practical and reduces electrocardiogram artifact (Potempa et al., 1996) .
Modifications can be made to exercise stress testing for poststroke survivors. Macko, Katzel, et al. (1997) developed and tested a customized low-velocity graded treadmill, with constant gait velocity, based on velocity during floor walking and a gradual increase in incline. They found that treadmill testing with modifications was feasible and safe in a population with chronic stroke. Potempa et al. (1995) developed a protocol using a bicycle ergometer with a fixed cycling rate and gradually increasing workload. The protocol was found to be safe and feasible.
We wished to incorporate bicycle ergometry for assessment of exercise safety and workload prescription into a randomized controlled trial of structured exercise for subacute-stroke survivors. We report on the baseline exercise-testing portion of the randomized controlled trial. The purposes of this article are to describe our screening and testing protocols; provide information about the safety, feasibility, and yield of the protocols; and offer physiological evidence about exercise performance in this population.
Methods

STUDY POPULATION
The participants in this study were enrolled in a randomized controlled trial to evaluate the benefits of a home-based, therapist-supervised exercise program. The participants were selected from the Kansas City Stroke Registry of stroke survivors in the Kansas City metropolitan area. Participants were recruited from 17 medical facilities and enrolled within 30-150 days after stroke onset. Stroke has been defined by the World Health Organization as "a rapid onset of an event of vascular origin reflecting a focal disturbance of cerebral function, excluding isolated impairments of higher function and persisting longer than 24 hours" (World Health Organization, 1989) . Diagnosis was confirmed by clinical assessment and/or a positive CT or MRI scan. Enrollment in the Kansas City Stroke Registry used standardized guidelines to meet the following criteria. Candidates were required to have had a confirmed, eligible stroke as defined by the World Health Organization criteria; age ≥50; stroke onset within 3-28 days; and residence within a 50-mile area. Candidates were excluded if they had a subarachnoid hemorrhage; were lethargic, obtunded, or comatose; or had uncontrolled blood pressure, hepatic or renal failure, NYHA III/ IV heart failure, known limited life expectancy, prestroke disability in self-care, or prior need for nursing home care. This study was approved by the participating institutional review boards, and informed consent was obtained from all participants.
Participants from the Kansas City Stroke Registry were eligible to be screened for a randomized controlled trial of structured exercise. Using standardized written guidelines, inclusion criteria for the trial were ability to ambulate 25 ft independently, Folstein Mini-Mental Status Exam score ≥16 (Folstein, Folstein, & McHugh, 1975) , mild to moderate stroke deficits defined by a Fugl-Meyer score of 27-90 for upper and lower extremity (Fugl-Meyer, Jaasko, Leyman, Olsson, & Steglind, 1975) , possessing palpable wrist extension on the involved side, and an Orpington Prognostic Scale score of 2.0-5.2 (Kalra & Crome, 1993) . Specific exclusions related to heart disease included hospitalization for myocardial infarction or heart surgery (CABG or valve replacement) during the preceding 3 months, documented serious cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, pulmonary embolus, or hospitalization for congestive heart failure during the preceding 3 months. Screening of registry participants for the trial occurred during home visits scheduled every 30 days from time of enrollment in the registry up to 120 days poststroke. The home visits were used to assess stroke recovery and identify any conditions that might affect eligibility. Once an eligible individual was identified, approval was sought from the participant's primary-care physician. A separate informed consent, approved by the participating institutional review boards, was obtained. The bicycle ergometry test was the last step in the screening and eligibility process; only those who had passed every other eligibility screen were tested.
STUDY DESIGN
This study used cross-sectional baseline data on participants enrolled in the clinical trial.
PROCEDURES
All participants who met the inclusion criteria underwent a baseline graded cardiac stress test within 30-150 days poststroke. The protocol used in this study was modified from Potempa and colleagues (1995) . Minor modifications were made to adapt to the specific impairments of the participants. For example, participants with weakness about the ankle had their feet stabilized on the pedal with external wrapping using a soft elastic bandage. Before initiating the test, a study therapist completed a cardiovascular screening form with the participant. This form gathered information regarding cardiovascular history (e.g., previous myocardial infarctions, cardiac surgeries, abnormal heart rhythms, valvular heart disease, rheumatic heart disease, hypertrophic cardiomyopathy), chest discomfort, heart-disease risk factors (hypertension, cholesterol, diabetes, smoking, and family history), and current medications. The study cardiologist reviewed this information before the graded exercise test was started.
Calibration for the Medical Graphics CardiO 2 breath-by-breath exercise system (Medical Graphics Corp., St. Paul, MN) was initiated 30 min before the start of the test. The current temperature, barometric pressure, and humidity were entered into the system. Manual calibration of the system was completed just before the exercise session was started, according to the manufacturer's recommendations. The flow module with a PreVent flow-sensing device was calibrated with a precision 3.0-L-volume syringe using a series of different flow patterns. The CO 2 and O 2 analyzers were calibrated using a two-point calibration routine: a room-air reference gas and a calibration gas (CO 2 5%, O 2 12%, balance N 2 ). System calibration was reverified after the completion of each exercise session.
Participants were instructed in the testing procedures and oriented to a 15-point Borg rating of perceived exertion (Borg, 1982) . The exercise protocol began with the participant seated on the bicycle ergometer with feet secured in toe clips and elastic wrap. The participant sat quietly without pedaling for 2 min. Dynamic exercise began with the participant pedaling at 60 revolutions per min (rpm) and 0 W of workload. The workload was increased by 10 W each minute. Verbal encouragement was standardized and offered every minute. If needed, additional reminders to pedal at 60 rpm were given if the cadence dropped to less than 55 rpm. Testing continued until maximal effort was achieved. Maximal effort was defined as the achievement of 90% maximal predicted heart rate (maximum heart rate = 220 -age). The test was terminated before achieving maximum heart rate (HR) for predefined symptomatic, clinical, and electrocardiographic criteria. Symptomrelated reasons for termination were angina, dyspnea, and fatigue. Fatigue was defined as either voluntary exhaustion or the inability to maintain a cycling cadence of 40 rpm. Clinical criteria for termination included hypertension (≥220/120) or hypotension (a drop in diastolic blood pressure >20 mmHG) and O 2 saturation <85%. Electrocardiogram criteria included ≥1 mm horizontal or down-sloping STsegment depression, sustained paroxysmal ventricular tachycardia (>30 beats), and sustained paroxysmal supraventricular tachycardia (>30 beats). No changes in medications were made during the testing procedures. When the test was terminated, a cool-down period followed. The workload was decreased to 0 W, and the participant pedaled at 40 rpm for an additional 4 min. If a test was terminated because of electrocardiographic findings, the participant was managed medically as needed, referred for further care, and disapproved for the exercise trial.
MEASUREMENTS
Blood Pressure. Brachial-artery blood pressure from the participant's unaffected upper extremity was measured using an automated blood-pressure monitor (DeBusk Model 9600). Resting blood pressure was determined after the participant sat on the stationary bicycle for 1 min before initiating exercise. Blood-pressure readings were obtained every minute during the graded exercise test.
Exercise Metabolic Parameters.
HR, oxygen consumption (VO 2 ), carbon dioxide (VCO 2 ), and respiratory exchange ratio were continuously recorded during the resting period, dynamic exercise test, and cool-down. A breath-by-breath respiratory-gas-analysis system was used with computerized software (Medical Graphics Cardiopulmonary O 2 /Combined VO 2 /ECG Exercise System).
Heart Rate. HR was obtained from the ECG. Resting HR was obtained after the participant sat on the stationary bicycle for 1 min. Maximal HR achieved was recorded as the highest HR achieved during the dynamic exercise.
Workload. The electronic ergometer system maintained the specified workload and automatically increased it by 10 W/min. Participants were asked to maintain a cycling cadence of 60 rpm. The maximal workload for each graded exercise test was the highest workload achieved.
Exercise Time. Exercise time was the total amount of time, measured in seconds, from the first downward stroke of the pedal until the participant stopped pedaling, excluding cool-down.
Rating of Perceived Exertion. After completing the dynamic exercise test, the participants were asked, At the time the resistance was removed and the cycling became easier, how hard were you working? Participants responded by pointing to the appropriate number on the 15-point Borg scale.
Anaerobic Threshold. The anaerobic threshold was determined by using the V-slope method (Wasserman, Hansen, Sue, Casaburi, & Whipp, 1999) . When expired carbon dioxide is plotted against oxygen consumption, the resulting curve is composed of two apparently different linear components. The anaerobic threshold, as measured by gas exchange, is the intercept of these two slopes.
RELIABILITY OF TESTING PROCEDURES
To establish reliability of the test in this population, 9 participants completed two graded exercise tests, 1 week apart. Intraclass correlation coefficients (ICCs) were calculated for the primary outcomes. ICCs were maximal HR (.88), percentage of maximal HR (.85), peak VO 2 (.98), peak METs (.84), total exercise duration (.94), VO 2 at anaerobic threshold (.96), METs at anaerobic threshold (.89), and exercise duration to anaerobic threshold (.95).
STATISTICAL ANALYSIS
Simple descriptive statistics are provided for the demographic, feasibility, safety, and exercise-performance data. Means and standard deviations were computed for the continuous variables. Frequencies and percentages were calculated for the categorical variables. Fisher's exact test and t tests were used to compare characteristics of those able and unable to complete the test.
Results
We screened 583 participants for the study, and 466 were not eligible. The primary reasons for exclusion are presented in Table 1 . Many participants met more than one exclusion criterion. The most common reasons for exclusion were not related to exercise testing specifically; they were related to degree of stroke recovery or overall functional status. One hundred seventeen participants who were eligible for the randomized controlled trial agreed to bicycle ergometry, and 100 participants completed the test. Fourteen participants were unable to perform the exercise stress test, and 3 failed because of cardiac safety criteria during exercise.
The 117 participants who participated in the exercise stress test are described in the first column of Table 2 . These participants had moderate stroke deficits as defined by the Orpington Prognostic Scale, with a mean score of 3.4 and a range of 2.0-5.6. The mean time since stroke was 72 days. Thirty-three percent had a history of ischemic heart disease, 10% had a history of CHF, 22% were on beta-blockers, 21% had atrial fibrillation, and 6% had pacemakers. The remaining columns of Table 2 describe participants who completed the test, participants who were unable to perform the test, and participants who failed the test. Overall, 100 of 117 (85%) participants safely completed the graded exercise test, 3 failed it, and 14 did not complete it. Participants unable to complete the test had had significantly more brainstem strokes (p = .036), more severe stroke by the Orpington scale (p = .041), and a longer time period from stroke onset to test (p = .015).
Fourteen participants were unable to perform the graded exercise test. Eight were unable to pedal at the required 40 rpm, 2 lacked adequate knee flexion for pedaling, 2 had a resting blood pressure that was too high, 1 was unable to ride the bike, and 1 was unable to tolerate the mouthpiece. Three participants failed for cardiac reasons. There was one case of asymptomatic ventricular tachycardia lasting initially 10 beats, followed by a second run lasting 1 min. There was one case of sustained paroxysmal supraventricular tachycardia and one case of ≥1 mm horizontal ST-segment depression. The participants who experienced these events remained conscious and did not experience any altered blood pressure or oxygenation. The participant who experienced ventricular tachycardia was hospitalized for observation, per protocol, for 36 hr. In each of these cases, results were provided to the patient and the referring physician. (36) 4 (29) .77 0 history of CHF, (n) % 12 (10) 12 (12) 2 (14) .68 1 (33) atrial fibrillation, (n) % 24 (21) 20 (20) 2 (14) 1.00 0 current beta blockers, (n) % 22 (19) 22 (19) 3 (21) 1.00 1 (33) pacemaker, (n) % 7 (6) 7 (7) One hundred participants completed the test. Testing was terminated in 24 participants for achieving 90% of maximum HR, in 13 participants for high blood pressure, and in 63 participants for exhaustion. Exercise performance is presented in Table 3 . The maximum exercise capacity in these participants was 3.3 METs, reached in an average of 5.1 min. Seventy-one participants achieved anaerobic threshold, in 2.98 ± 1.68 min. The peak VO 2 at the point of anaerobic threshold was 8.6 ± 1.7 ml · kg · min -1 , or 2.45 ± 0.49 METs.
Discussion
A bicycle-ergometry graded exercise test is feasible and safe in subacute-stroke survivors who have been thoroughly screened. The protocol safety parameters allow the procedure to be completed with a low failure rate. Subacute-stroke survivors have such severe exercise limitations that they reach aerobic capacity and anaerobic threshold at MET levels that would interfere with self-care activities and daily function. Endurance testing and training have not been part of stroke rehabilitation because the focus has been on neurological rather than cardiovascular impairments. We found such a severe level of deconditioning (peak aerobic capacity only 11.4 ml · kg · min -1 , or 3.3 METs) that usual activities such as bathing, grocery shopping, and climbing stairs would precipitate fatigue (American College of Sports Medicine, 1998). Endurance has previously been shown to be limited in chronic stroke patients. Persons with chronic stroke and a mean age of 56 years who were tested 14.4 ± 2.6 N/A N/A using bicycle ergometry had a baseline maximum aerobic capacity of 15-16 ml · kg · min -1 (Potempa et al., 1995) . Another cycle-ergometry study found a VO 2max of 16.1 ml · kg · min -1 in 8 chronic stroke patients who had a mean age of 52.4 years (Bachynski-Cole & Cumming, 1985) . The even lower level of endurance found in our study might result in part from the older age of our sample.
In order to start conditioning exercise as part of stroke rehabilitation, exercise safety in this high-risk population must be addressed. This protocol offers guidelines for safety screening before testing that yielded a very low rate of tests that had to be stopped for safety reasons. The protocol itself was feasible; 85% of participants completed it.
This study aimed to test exercise capacity and safety; it was not designed to detect all ischemic heart disease. Exercise testing was terminated in 3 individuals because of cardiac endpoints. Surprisingly, only 1 patient developed ischemic electrocardiographic (ST-segment) abnormalities with exercise. Cerebrovascular and coronary-artery disease both represent forms of atherosclerotic vascular disease and occur in patients with similar risk profiles. Therefore, patients with stroke are expected to have increased risk for coexistent coronary disease and for coronary events including death and nonfatal myocardial infarction. There might be several explanations for the very low rate of ischemic exercise responses noted in this study. First, the exclusion criteria defined all those with recent cardiac events or symptoms of angina as ineligible. Second, this submaximal exercise test achieved an average of only 75% of predicted maximal HR. In the study reported by Macko the average HR response was higher, at 84% of predicted maximal (Macko, Katzel, et al., 1997) . Moreover, ST-segment abnormalities might not be a sensitive means of judging an ischemic exercise response, especially when the abnormality is of borderline significance or when considerable exercise artifact is present. It is very likely that some form of postexercise imaging, either by thallium scanning or echocardiography, would enhance the sensitivity for an ischemic response.
Most participants terminated the test because of exhaustion without reaching predicted maximum HR. Exercise to exhaustion is a realistic indicator of functional endurance, although it might limit detection of asymptomatic heart disease. The testing protocol allowed for assessment of symptoms, signs, and electrocardiographic abnormalities during endurance exercise comparable to the planned endurance intervention. This testing protocol does provide a mechanism for designing a safe way to start endurance training in stroke patients. It is most useful for assessing safety before a moderate-intensity program.
The study sample does not represent all stroke survivors, but it is highly relevant to the type of patient who would be considered for endurance training. Stroke patients with mild to moderate deficits are most likely to tolerate and desire conditioning. Those with more severe strokes could not perform the proposed testing or training. Patients with very mild deficits would not need the special adaptations such as foot stabilizers described here. The age distribution of our sample is older than in previous studies in chronic stroke and more representative of the age of the general stroke population (American Heart Association, 2001).
We studied subacute rather than chronic stroke. Prior studies have demonstrated feasibility in chronic stroke patients. We now show that testing can be feasible and safe as early as 1 month after a stroke. We believe that endurance training should begin earlier in the natural history of stroke recovery. Inactivity because of neurological deficits leads to further deconditioning and a vicious cycle of inactivity. Interventions to improve endurance earlier during recovery might enhance patients' capacity to participate in neurorehabilitative activities and reenter the community.
In summary, a bicycle-ergometry graded exercise test is well tolerated and safe in a subacute-stroke population with mild to moderate deficits, after structured screening. Our protocol led to a very small rate of failure caused by cardiac complications and to a high completion rate. Patients in the subacute phase of recovery from mild to moderate stroke have an extremely low functional-exercise capacity that is likely to interfere with their daily function and rehabilitation. Strokerehabilitation research and clinical practice should incorporate more comprehensive evaluation and treatment of limitations in endurance.
